Paranovus Entertainment Technology Ltd.

NASDAQ:PAVS

Medical - Pharmaceuticals

Healthcare
$7.02 +20.81%

+$1.28 today

Market cap
$353.07M
Beta
-0.35
P/E (TTM)
-0.7
EPS (TTM)
-$9.07
52W Low $5.69High $148,800.00

Volume 0.16M

Average 113.44M

PAVS Depreciation & Amortization

Non-cash expense that spreads the cost of physical and intangible assets over their useful lives.

Paranovus Entertainment Technology Ltd.NASDAQ: PAVS

Depreciation & Amortization · Q2 FY2025 · quarter ended Sep 2025

Depreciation & amortization grows 468.9% year over year

Q2 FY2025 depreciation & amortization of $1.08M rose 468.9% year over year. Over 3 fiscal years it compounded at -44.2% a year.

Context

  • Depreciation & amortization amounted to 531.2% of revenue in FY2024.
  • Depreciation & amortization increased in 1 of the last 3 fiscal years.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterSep 2025
$1.08M— QoQ
Last fiscal yearMar 2025
$380K+0.0% YoY
Depreciation & Amortization past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+468.9%——
1 year+0.0%——
3-year CAGR-44.2%——
5-year CAGR——
10-year CAGR——

Depreciation & Amortization history

USD · from the income statement

Latest · FY2024
380K USD
Year-over-year change
+0.0%
4-year CAGR
-19.0%

Depreciation & Amortization vs competitors

How PAVS compares with its peers on the latest reported figures

  • PAVS's FY2024 depreciation & amortization of $380K is the 3rd highest of the 4 companies compared; the peer median is $672.23K.
  • Its year-over-year change of +0.0% is the lowest of 4, against a peer median of +35.2%.
  • Depreciation & amortization amounts to 531.2% of revenue for PAVS, versus a peer median of 4.5%.
PAVS Competitors Peer median
Depreciation & Amortization for PAVS and competitors
Company Period LTM YoY 3-year CAGR% of revenue
WYHGWing Yip Food Holdings Group Limited American Depositary SharesLTM Mar 2026$5.89M +6.6%+18.9%4.5%
BOFBranchOut Food Inc.LTM Mar 2026$672.23K +122.6%+87.7%5.1%
PAVSParanovus Entertainment Technology Ltd.FY2024$380K +0.0%-44.2%531.2%
LSFLaird Superfood, Inc.LTM Mar 2026$358.87K +35.2%-39.0%0.8%
Peer median (excluding PAVS) $672.23K+35.2%+18.9%4.5%

Competitors are the stored peer set for PAVS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2020
Mar 2021
FY2021
Mar 2022
FY2022
Mar 2023
FY2023
Mar 2024
FY2024
Mar 2025
Revenue71.48M89.49M23.33M071.54K
Cost of Revenue53.31M85.78M22.92M380K442.53K
Gross Profit18.18M3.71M416.88K(380K)(370.98K)
Gross Margin25.4%4.1%1.8%—-518.6%
Research & Development1.66M1.68M1.4M00
Selling, General & Admin14.99M49.6M4.97M2.08M1.93M
Operating Expenses16.65M51.29M4.97M2.08M1.93M
Depreciation & Amortization880.88K2.19M58.75K380K380K
EBITDA2.41M(45.39M)(4.49M)(2.08M)(1.92M)
EBITDA Margin3.4%-50.7%-19.2%—-2682.4%
Operating Income1.53M(47.58M)(4.55M)(2.46M)(2.3M)
Operating Margin2.1%-53.2%-19.5%—-3213.6%
Interest Income131.9K108.4K3160156
Interest Expense111.8K85.99K72.3K39.17K261.85K
Other Income / Expenses125.62K(10.17M)22.04K(1.83M)(4.7M)
Income Before Tax1.65M(57.75M)(4.53M)(4.29M)(7M)
Pre-Tax Margin2.3%-64.5%-19.4%—-9788.2%
Income Tax Expense959.38K(3.73M)3K00
Net Income786.36K(49.19M)(71.74M)(17.67M)(7.53M)
Net Margin1.1%-55.0%-307.5%—-10519.7%
EPS (Basic)72.14(2,916.00)(1,516.10)(448.12)(10.69)
EPS (Diluted)72.14(2,916.00)(1,516.10)(448.12)(10.69)
Weighted Avg Shares10.9K16.86K47.31K39.43K704.27K
Weighted Avg Shares (Diluted)10.9K16.86K47.31K39.43K704.27K

Paranovus Entertainment Technology Ltd.

NASDAQ:PAVS

Intrinsic Alpha fair value

Locked

Current Price

$7.02

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.